A widely recognized treatment for autism, considered the "gold standard" in autism care, is being limited by states and insurance providers. The reasons for this limitation are unclear, with some reports suggesting concerns about the treatment's effectiveness and potential harm to patients' mental health, while others indicate that doctors are hesitant to prescribe it. The impact of these limitations on access to care for children with autism is also a point of concern.